Worcester Internal Medicine

CLIA Laboratory Citation Details

2
Total Citations
7
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 22D0718726
Address 416 Belmont St, Worcester, MA, 01604
City Worcester
State MA
Zip Code01604
Phone(508) 756-6609

Citation History (2 surveys)

Survey - July 25, 2023

Survey Type: Standard

Survey Event ID: 8IY211

Deficiency Tags: D0000 D6000 D6011

Summary:

Summary Statement of Deficiencies D0000 A CLIA COLA validation survey was conducted for the Worcester Internal medicine, Inc. laboratory pursuant to the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and CLIA regulations at 42 CFR 493. . D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on record review and interview the laboratory had implemented test systems and procedures that were high complexity and were not under the management and direction of a laboratory director who qualified under 493.1443 of this subpart as evidenced by the following: Sysmex KX21N hematology analyzer: a) In October of 2020 the laboratory implemented the Sysmex KX21N hematology analyzer. The lab attempted to get Sysmex reagents for the analyzer but, because it was not purchased from the company directly, the company would not sell the required reagent to them. b) According to the technical consultant interviewed on 7/25/23, the laboratory purchased off brand reagents from another company and was utilizing the hematology analyzer using the off brand reagents for patient testing and reporting. The utilization of off brand reagents is a modification of the test system and therefore considered high complexity. At the time of the survey, the laboratory was not under the direction of a laboratory director who qualified under high complexity testing. Urine culture screens: a) A review of twenty seven (27) patient reports for testing performed between 4/2/21 and 7/10/23 revealed that for one (1) of the twenty seven (27) reports the lab reported 1000 mixed on a urine culture screen (laboratory accession # 82116). Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- The reporting of mixed culture growth is considered high complexity. At the time of the survey, the laboratory was not under the direction of a laboratory director who qualified under high complexity testing. D6011 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(2) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(2) and provide a safe environment in which employees are protected from physical, chemical, and biological hazards. This STANDARD is not met as evidenced by: Based on observation on 7/25/23 at 12:36 PM, the laboratory director failed to provide a safe environment environment in which employees are protected from chemical and biological hazards as evidenced by the following: a) On the day of the survey in the presence of the technical consultant, it was observed that there were two fire extinguishers on the floor that were no mounted and secured. b) On the day of the survey in the presence of the technical consultant, it was observed that the laboratory area where testing was performed was carpeted creating a potential biohzard. . -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 23, 2019

Survey Type: Standard

Survey Event ID: HBNU11

Deficiency Tags: D0000 D2007 D5477 D6011

Summary:

Summary Statement of Deficiencies D0000 A CLIA COLA validation survey was conducted for the Worcester Internal medicine, Inc. laboratory pursuant to the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and CLIA regulations at 42 CFR 493. . D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on proficiency testing record review and confirmed through an interview on 4 /23/19 at 10:21 AM with one testing person, the laboratory failed to ensure that one (1) out of two (2) testing personnel tested proficiency testing samples as evidenced by the following: 1. A review of proficiency testing record attestation statements for calendar years 2017, 2018, and 2019 (seven testing events) revealed that only one of the personnel performing moderate complexity testing was also performing proficiency testing samples (documented signature on the attestation form). Records of proficiency testing for testing person number 2 only started in calendar year 2019. 2. Testing person number 1 interviewed confirmed that she was the only person routinely performing proficiency testing samples up until 2019. . D5477 CONTROL PROCEDURES CFR(s): 493.1256(e)(4)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e) (4) Before, or concurrent with the initial use-- (e)(4)(i) Check each batch of media for sterility if sterility is required for testing; (e)(4)(ii) Check each batch of media for its ability to support growth and, as appropriate, select or inhibit specific organisms or Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- produce a biochemical response; and (e)(4)(iii) Document the physical characteristics of the media when compromised and report any deterioration in the media to the manufacturer. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on record review and interview , the laboratory failed to check each batch of media for sterility, its ability to support growth and, as appropriate, select or inhibit specific organisms or produce a biochemical response before or concurrent with initial use as evidenced by the following: a) The laboratory performs urine culture screens utilizing Uricult microbiological media paddles. b) A review of bacteriology quality control records for calendar year 2018 and 2019 (fifteen and a half (15 and 1/2) months of laboratory operation) revealed that the laboratory failed to check each lot number or shipment of Uricult microbiological media for its ability to support growth and, as appropriate, select or inhibit specific organisms. c) Testing person number 1 confirmed in an interview on 4/23/19 at 11:30 AM that the Uricult microbiological media had not been checked for it's ability to support growth and, as appropriate, select or inhibit specific organisms. . D6011 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(2) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(2) and provide a safe environment in which employees are protected from physical, chemical, and biological hazards. This STANDARD is not met as evidenced by: Based on observation, the laboratory director failed to provide a safe environment environment in which employees are protected from chemical and biological hazards as evidenced by the following: a) On the day of the survey in the presence of two (2) laboratory technologists, it was observed that there was no permanently mounted eyewash which would provide fifteen minutes of continuously flowing water near the laboratory area. b) Testing person number 1 confirmed in an interview on 4/23/19 at 9: 49 AM that there was no permanently mounted eyewash available in the facility. . -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access